These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6333320)

  • 21. Clinical and serum lipid findings in a large family with autosomal dominant retinitis pigmentosa.
    Newsome DA; Anderson RE; May JG; McKay TA; Maude M
    Ophthalmology; 1988 Dec; 95(12):1691-5. PubMed ID: 3266001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual Function in Carriers of X-Linked Retinitis Pigmentosa.
    Comander J; Weigel-DiFranco C; Sandberg MA; Berson EL
    Ophthalmology; 2015 Sep; 122(9):1899-906. PubMed ID: 26143542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in copper and zinc levels in the serum, erythrocytes and urine of patients with retinitis pigmentosa].
    Kubalska J; Sliwińska J; Skubiszewska T; Krajewska-Walasek M; Pietraszek E; Pronicka E
    Pediatr Pol; 1984 Mar; 59(3):209-16. PubMed ID: 6539906
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical symptoms at different ages in autosomal dominant retinitis pigmentosa. A family study in three generations.
    Mäntyjärvi M; Tuppurainen K
    Ophthalmologica; 1994; 208(1):23-8. PubMed ID: 8145980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vision threshold profiles in X-linked retinitis pigmentosa.
    Massof RW; Finkelstein D
    Invest Ophthalmol Vis Sci; 1979 Apr; 18(4):426-9. PubMed ID: 311766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long-term follow-up of deterioration of the visual field in visual acuity in retinitis pigmentosa].
    Schmidt JG; Zinser J
    Fortschr Ophthalmol; 1989; 86(6):614-8. PubMed ID: 2625290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular manifestations in autosomal dominant retinitis pigmentosa with a Lys-296-Glu rhodopsin mutation at the retinal binding site.
    Owens SL; Fitzke FW; Inglehearn CF; Jay M; Keen TJ; Arden GB; Bhattacharya SS; Bird AC
    Br J Ophthalmol; 1994 May; 78(5):353-8. PubMed ID: 8025068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mathematical models of retinitis pigmentosa: a study of the rate of progress in the different genetic forms.
    Pearlman JT
    Trans Am Ophthalmol Soc; 1979; 77():643-56. PubMed ID: 317544
    [No Abstract]   [Full Text] [Related]  

  • 29. Retinitis pigmentosa: a review.
    Krill AE
    Sight Sav Rev; 1972; 42(1):21-8. PubMed ID: 4555922
    [No Abstract]   [Full Text] [Related]  

  • 30. Cone and rod function in vitamin A deficiency with chronic alcoholism and in retinitis pigmentosa.
    Sandberg MA; Rosen JB; Berson EL
    Am J Ophthalmol; 1977 Nov; 84(5):658-65. PubMed ID: 303866
    [No Abstract]   [Full Text] [Related]  

  • 31. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa.
    Hoffman DR; Locke KG; Wheaton DH; Fish GE; Spencer R; Birch DG
    Am J Ophthalmol; 2004 Apr; 137(4):704-18. PubMed ID: 15059710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinitis pigmentosa without pigment.
    Pearlman JT; Flood TP; Seiff SR
    Am J Ophthalmol; 1976 Apr; 81(4):417-9. PubMed ID: 1083673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotype of retinitis pigmentosa associated with the Ser50Thr mutation in the NRL gene.
    Bessant DA; Holder GE; Fitzke FW; Payne AM; Bhattacharya SS; Bird AC
    Arch Ophthalmol; 2003 Jun; 121(6):793-802. PubMed ID: 12796249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unique characteristics of two types of retinitis pigmentosa patients with different rod sensitivities.
    Takahashi H; Miyake Y; Horiguchi M; Tomida N; Takakuwa H
    Jpn J Ophthalmol; 2005; 49(2):114-20. PubMed ID: 15838727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum ceruloplasmin and immunoglobulins in retinitis pigmentosa patients.
    Jain IS; Singh KP; Dhir SP
    Ann Ophthalmol; 1981 Jun; 13(6):733-4. PubMed ID: 7258970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biochemical studies on serum-lipids and -proteins in retinitis pigmentosa: abnormalities of serum beta-lipoprotein concentration in retinitis pigmentosa (author's transl)].
    Kajiwara Y
    Nippon Ganka Gakkai Zasshi; 1977 Nov; 81(11):1723-32. PubMed ID: 207176
    [No Abstract]   [Full Text] [Related]  

  • 37. [An electronic visual aid using a luminance amplifier in night vision disorders].
    Alaux F; Chauveau N; Bec P; Morucci JP
    J Fr Ophtalmol; 1986; 9(3):191-7. PubMed ID: 3490504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different amino acid substitutions at the same position in rhodopsin lead to distinct phenotypes.
    Neidhardt J; Barthelmes D; Farahmand F; Fleischhauer JC; Berger W
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1630-5. PubMed ID: 16565402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expanded Retinal Disease Spectrum Associated With Autosomal Recessive Mutations in GUCY2D.
    Stunkel ML; Brodie SE; Cideciyan AV; Pfeifer WL; Kennedy EL; Stone EM; Jacobson SG; Drack AV
    Am J Ophthalmol; 2018 Jun; 190():58-68. PubMed ID: 29559409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of thyroid disease with retinitis pigmentosa and gyrate atrophy.
    Whitcup SM; Iwata F; Podgor MJ; Valle D; Sran PK; Kaiser-Kupfer MI
    Am J Ophthalmol; 1996 Dec; 122(6):903-5. PubMed ID: 8956655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.